Apoptosis deficiency is a hallmark of many cancer cells. Functional suppression of specific antiapoptotic factors might provide a feasible strategy in cancer gene therapy. Livin, the latest found inhibitor of apoptosis protein (IAP) family member, plays important role in cell growth and apoptosis. It has been reported that Livin is highly expressed in bladder cancer tissues. In this study, we found that, unlike other cancer cell lines, there was only Livin-not Livin-expression in bladder cancer cell lines. We further investigated the effects of Livin knockdown on human bladder cancer T24 cell growth and apoptosis. We found that small interfering RNA (siRNA) mediated Livin suppression significantly inhibited T24 cell proliferation and colony formation ability. Livin knockdown dramatically increased the T24 cell apoptotic rate in response to different proapoptotic stimuli, such as Mitomycin and TNF-alpha, and this was associated with caspase-3 and caspase-9 activation. These results suggest that Livin knockdown can inhibit cell growth and increase sensitivity to apoptotic stimuli, and might serve as a potent target in bladder cancer gene therapy.
Bladder cancer is one of the most common malignant tumors in the urinary system. Until now the most effective treatments are surgical operation plus intravesical chemotherapy. However, two things that frustrate surgeons, mostly after an operation, are a high reoccurrence rate and the increased chemoresistance of bladder cancer. 1) Patients suffer a lot from repeated operations and chemotherapy due to the unsatisfactory character of current treatment methods.
The recently found IAP family member Livin, also named ML-IAP or KIAP (in the following termed Livin), has been reported to be almost exclusively expressed in cancers and not, or at substantially lower levels, in corresponding normal tissues.
2) There are two alternative splicing variants of Livin, Livin-and Livin-, similar except for 18 amino acids located between the BIR and RING domains, which are present only in the former. Two functional domains, including BIR and RING, give Livin potent antiapoptotic ability by inhibiting both external and internal apoptosis pathways. [3] [4] [5] The high expression of Livin in tumor cells suggests that it can contribute to tumorigenesis and chemoresistance by inhibiting apoptosis. 6) CrnkovicMertens found that suppression of Livin in Hela cells was associated with a strongly increased apoptotic rate in response to different proapoptotic stimuli. 7) Wang and colleagues reported that knockdown Livin expression led to cell cycle redistribution and increased the apoptosis index in Lovo and SPCA-1 cell lines. 8) Furthermore, it has been reported that Livin was highly expressed in bladder cancer, but not in normal bladder tissue. 9, 10) Therefore, it is possible that Livin plays an important role in the development of bladder cancer and can serve as a potential target in bladder cancer gene therapy.
RNA interference (RNAi) is considered a powerful biological tool that suppresses gene expression posttranscriptionally in plants and animals. 11) In mammalian cells, a single strand of 19-21 nucleotide small interference RNA (siRNA), which is complementary to mRNA, can lead to target-special mRNA cleavage by the RISC complex, which causes special gene silencing. 12, 13) Apart from being a useful new gene function analysis strategy at the cellular level, inhibition of defined gene by siRNAs has obvious therapeutic implications in the clinic.
Here, we found that expression of Livin in bladder cancer could be blocked efficiently and specifically through RNAi. Suppression of Livin expression in T24 cells is correlated with cell proliferation and apoptotic sensitivity.
Materials and Methods
Cell culture. Human bladder cancer cell lines T24, 5637, EJ, and BIU-87, and the human lung cancer cell line, SPCA-1, were obtained from Shanghai Cell Bank, Chinese Academy of Sciences (Shanghai, China). All of the above cell lines were maintained in RPMI 1640 (Hyclone, Logan, UT) supplemented with 10% fetal bovine serum y To whom correspondence should be addressed. Tel: +86-411-83635963-2102; Fax: +86-411-83622844; E-mail: songxishuang@gmail.com Abbreviations: IAPs, inhibitor of apoptosis proteins; siRNA, small interfering RNA; siRNA-NC, siRNA-negative control; TUNEL, terminal deoxynucleotide transferase-mediated-dUTP nick end labeling (Hyclone), 100 U/ml of penicillin, and 100 mg/ml of streptomycine under a humidified atmosphere of 95% air and 5% CO 2 .
RT-PCR assay. Total RNA was isolated from the cells using Trizol (Invitrogen, Carlsbad, CA), and cDNA was synthesized using a reverse transcriptase polymerase chain reaction (RT-PCR) kit (Takara, Dalian, China) according to the manufacturer's instructions. The sequences of the primers were as follows: 5 0 -AGTTCCTGCTCCGGTCAAA-3 0 (F) and 5 0 -GCACGGCACAAAGACGAT-3 0 (R) for Livin, and 5 0 -AGC-GAGCATCCCCCAAAGTT-3 0 (F) and 5 0 -GGGCACGAAGGCTCAT-CATT-3 0 (R) for human actin beta (-actin). Polymerase chain reaction analysis was performed under the following conditions: denaturation at 95 C for 3 min, and then 30 cycles of denaturation for 20 s at 94 C, annealing for 30 s at 55 C, and extension for 30 s at 72 C. The amplified products were analyzed by agarose gel electrophoresis using 1.0% gel, followed by ethidium bromide staining. DL2000 Marker was served as the molecular weight standard.
Western blot analysis. The denatured proteins were mixed with 2 Â sodium dodecyl sulfate (SDS) sample buffer (0.5 M Tris-HCL pH 6.8, 10% SDS, 5% glycerol, and 5% -mercaptoethanol) and resolved by 12% SDS-PAGE and then blotted onto PVDF membranes (Pall, San Diego, CA). After blocking for 2 h with phosphate-buffered saline containing 0.1% Tween20 and 5% powdered skim milk, the blots were incubated with rabbit anti-human Livin, active caspase-3, active caspase-7, and caspase-9 polyclonal antibody (1:500 dilution, Santa Cruz Biotech, Santa Cruz, CA) overnight in 5% powdered skim milk buffer, washed 3 times with phosphate-buffered saline with 0.1% Tween20, and then incubated with secondary antibody anti-rabbit HRP (1:2,000 dilution, Santa Cruz Biotech). GAPDH antibody (1:500 dilution, Santa Cruz Biotech) was used as the control. All bands were detected using an ECL Western-blot kit (Amersham Biosciences, Buckinghamshire, UK).
Colony-formation assay in soft agar. Colony-formation assay in soft agar detected the transformation potential of the tumor cells. In brief, a bottom layer (0.6% low melt agarose) was prepared with PRIM 1640 medium containing 10% fetal bovine serum, 100 U/ml of penicillin, and 100 mg/ml of streptomycin. A top layer (0.3% agar) was prepared with PRIM 1640 and the media described above, but containing 5,000 indicated cells. The plates were incubated at 37 C in 5% CO 2 in a humidified incubator for about 14 d. they were then scanned and photographed, and the number of colonies was quantified with Quantity one v.4.0.3 software (Bio-Rad, Hercules, CA).
RNAi assay. T24 cells were incubated in a six-well tissue culture dish without antibiotics 18-24 h before transfection, resulting in 60-80% confluency. Control siRNA labeled with FAM and specific Livin (NM 139317) siRNAs (the sequences of siRNAs and their targeting positions are listed in Table 1 ) were mixed with LipofectamineÔ 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendation and added to the cells. After 6 h at 37 C, the medium was changed, and the cells were cultured in PRIM 1640 supplemented with 10% FBS. Transfection efficiency was observed under a fluorescence microscope. The silencing level of Livin was determined by western blot 1-10 d after transfection.
Apoptosis assay. The terminal deoxynucleotide transferase dUTP nick end labeling (TUNEL) technique was used to detect the 3 0 -OH ends of the DNA exposed during the internucleosomal cleavage process of apoptosis. After Livin RNAi, T24 cells were treated with 10 ug/ml mitomycin (Sigma, St. Louis, MO) for 18 h and 5,000 U/ml of TNF-alpha for 24 h. TUNEL assay was performed using an in situ Cell Death Detection Kit (Roche, Indianapolis, IN) according to the manufacturer's protocol. Briefly, formaldehyde fixed cells were rinsed in PBS and immersed in equilibration buffer (5 min, 37 C). Then the slides were incubated with a mixture of TdT and fluorescein-dUTP (1:9) for 60 min at 37 C. After they were washed in PBS, The slides were sealed with clear nailpolish and observed under a fluorescence microscope.
Statistical analysis. SPSS13.0 software was used. Each assay was performed at least 3 times. The data were expressed as mean AE SD, and Student's t test was used to determine the significance of differences in multiple comparisons.
Ã p < 0:05 was considered to be statistically significant.
Results
Livin expression in bladder cancer cell lines Four bladder cancer cell lines, T24, 5637, EJ, and BIU-87, were selected to detect Livin expression both at the mRNA and the protein level by RT-PCR and Western Blot. As shown in Fig. 1 , both Livin-and Livin-were detected in lung cancer cell SPCA-1, which was selected as positive control. Unexceptionally, only Livin-was obviously expressed in the four bladder cancer cell lines; Livin-was undetectable. This result indicates that Livin-, but not Livin-, was commonly expressed in bladder cancer cell lines and might play important roles in tumor proliferation and apoptosis. Since the high grade bladder cancer T24 cells had the highest Livin expression, they were taken as the study target.
Livin expression in the T24 cell line can be knocked down specifically and efficiently by siRNAs
To minimize the off-target effect of RNAi, five Livin siRNAs that have been demonstrated capable of suppressing Livin expression in T24 cells (data not shown) were mixed together as a pool that was named siRNALivin. The transfection efficiency of FAM-labeled negative control siRNA into T24 cells was evaluated at more than 90% under a fluorescence microscope ( Fig. 2A) . To determine the optimal dose-and timeresponse effects of suppressing Livin, the expression of Livin in T24 cells transfected with siRNA-Livin at various concentrations was detected by Western Blot at 24, 48, and 72 h post-transfection. As shown in Fig. 2B and C, 30 nM of siRNA-merge had a maximum downregulation of 86:64% AE 4:33% at 72 h. However, 10 nM of siRNA-merge with downregulation of 74:13% AE 4:33% was probably the optimal concentration because of the minimized off-target effect caused by the high concentration of siRNA.
Livin knockdown inhibited T24 cell proliferation and transformation
The effect of siRNA-mediated downregulation of Livin on T24 cell proliferation was investigated. Every 24 h after Livin RNAi, T24 cell numbers were determined by trypan blue counting. As shown in Fig. 3A , the cell numbers of the control groups, blank, mock, and siRNA-NC, observed on day 4 and day 5, increased significantly compared to the siRNA Livin group. This indicates that suppression of endogenous Livin by siRNA Livin resulted in significant inhibition of cell proliferation. Colony formation assay was performed to evaluate further whether Livin suppression would inhibit T24 cell transformation ability. To this end, the duration of the transient RNAi effect caused by siRNA Livin was evaluated by Western Blot in advance. The results showed that Livin expression reverted to the original level on the 8th day after siRNA-Livin transfection (data not shown), which indicates that siRNA-Livin can cause Livin suppression lasting for approximately 1 week in T24 cells. The result of colony formation assay was obtained on the 14th day. As shown in Fig. 3B , in spite of the recovery of Livin expression 1 week later, both the mean colony number and the mean colony size of the T24 cells were significantly decreased for 1 week absent Livin expression in the siRNA-Livin group as compared to the control groups. This indicates that suppress Livin expression by siRNA-Livin has a strong inhibitory effect on T24 cell colony formation capability, which is correlated with cell transformation potential.
Taken together, these results indicate that knockdown of Livin in T24 cells can inhibit cell proliferation and transformation capability in vitro.
Livin knockdown enhanced T24 cells sensitive to apoptosis stimuli
To analyze how Livin expression varies in T24 cells under apoptotic stress, western blot assay was performed. As shown in Fig. 4A , there was approximately a 2-fold increase in Livin expression when T24 cells were treated with mitomycin and TNF-alpha. This result implies that Livin was required for the T24 cells to resist apoptosis. In addition, although Livin expression was promoted in the presence of the apoptotic stimulus, it was significantly suppressed by 30 nM siRNA-Livin 48 h after transfection.
To determine whether siRNA-mediated suppression of Livin would sensitize T24 cells to proapoptotic stimulus, TUNEL analysis was performed. This allows the detection of apoptotic cells. As shown in Fig. 4B , in the absence of a proapoptotic stimulus, suppress Livin expression increased TUNEL-positive cells by 87:14% AE 5:28%, indicating that suppress Livin mildly increased the spontaneous apoptosis rate of T24 cells. However, in the presence of proapoptotic agents (mitomycin and TNF-alpha), the number of TUNELpositive cells increased dramatically (270:94% AE 18:65% and 304:42% AE 20:32% respectively) under siRNA-mediated Livin knockdown.
T24 cell apoptosis induced by siRNA-Livin was caspase-dependent
To determine whether siRNA-Livin induced apoptosis is caspase-dependent in T24 cells, the active forms of caspase-3, caspase-7, and caspase-9 were detected by western blot. As shown in Fig. 5 , siRNA-Livin clearly increased the concentration of the active form of caspase-3 following treatment of T24 cells with mitomycin and TNF-alpha (344:27% AE 27:18% and 255:82% AE 21:69% respectively) as compared with control transfected cells (115:24% AE 17:32%). The active form of caspase-9 significantly increased in the presence of mitomycin (217:93% AE 19:22%), but not TNF-alpha (72:35% AE 5:18%) as compared with the control transfected cells (88:17% AE 6:31%). However, there was no significant difference in active caspase-7 expression between the siRNA-Livin and the siRNA-NC group in the absence and the presence of the apoptotic stimulus.
Taken together, these results indicate that Livin knockdown significantly increased T24 cell sensitivity to apoptosis, especially under apoptosis stress such as mitomycin and TNF-alpha, and that this was associated with caspase-3 and caspase-9 activation.
Discussion
It is well known that deficiency of apoptosis is a hallmark of many cancers, and hence therapeutic strategies targeting the apoptotic pathway to decrease the apoptotic threshold have been widely studied in cancer treatment.
14) The latest identified IAP member Livin, which is almost exclusively expressed in tumors and not in their counterparts, capably blocked apoptosis through both extrinsic and intrinsic apoptotic pathways. Thus, it is an ideal molecular target in cancer therapy. implied that Livin is associated with poor prognosis and resistance to chemotherapy for bladder cancer.
In this study, we focused on whether suppressing Livin expression by siRNA in T24 cells would inhibit cell proliferation and enhance cell sensitivity to proapoptotic stimuli, especially chemotherapeutics. To this end, the first step was to identify specific, efficient Livin siRNAs. Traditionally, screening these siRNAs is money and time consuming work. However, with the accumulation of RNAi studies on certain genes and the advent of more rational siRNA design software, highly specific, efficient siRNAs against a given gene can be obtained through bioinformatics. The Livin siRNA-1 and siRNA-2 sequences were obtained from two independent Livin studies that been published. capably suppressed endogenous Livin expression in T24 cells. However, it is well-known that the off-target effect is considered the main side effect of RNAi. 17) Here we managed to minimize the off-target effect through deliberate siRNA design and BLAST, applying the lowest effective siRNA concentration (10 nM/ml) and using the Livin siRNA pool. 18, 19) Anchorage-independent growth is one of the hallmarks of transformation, which is considered the most accurate and stringent in vitro assay to detect malignant transformation of cells. 20) The soft agar colony formation assay is a common method of monitoring anchorage-independent growth through measuring proliferation in a semisolid culture media. Although the transient Livin RNAi effect due to siRNA-Livin only lasted for approximately 1 week in T24 cells, shorter than the colony formation assay time, it still caused an obvious decrease in the colony formation capability of T24/ siRNA-Livin cells as compared to the negative controls. This is in accordance with vector-based Livin RNAi studies. These results indicate that Livin plays an important role in bladder cancer cell transformation. However, the exact mechanism by which Livin regulates cell transformation requires further study.
It has been reported that Livin inhibition is associated with enhancement of apoptotic sensitivity. Like many chemotherapeutic reagents, mitomycin mainly triggers the intrinsic apoptosis pathway in cancer cells. 21, 22) Wang reported that the therapeutic effect of mitomycin, which is widely used to treat bladder cancer through intravesical instillation, could be enhanced by Smac (a mitochondria-released proapoptotic factor) in T24 cells. 23) In this study, siRNA-Livin-mediated Livin suppression rendered T24 cells much more sensitive to mitomycin. This is in accordance with previous results that Livin inhibited the intrinsic apoptosis pathway by ubiquitously degrading Smac. 24) These results indicate that Livin siRNAs together with mitomycin have a synergistic action on bladder cancer, which has important therapeutic implications for the clinic. In this study, we also observed that suppress Livin significantly increased T24 cell apoptosis sensitivity to TNF-alpha, which is considered main trigger of the extrinsic apoptosis pathway. 25) To sum up, apoptosis caused by mitomycin and TNF-alpha in T24 cells was enhanced by siRNA-mediated Livin suppression, and was associated with caspase-3 and caspase-9 activation.
Livin isoforms play different roles in cell apoptosis regulation. Crnkovic-Mertens et al. demonstrated that Livin contributed to Hela cell growth and resistance to proapoptotic stimulus. 7) Moreover, they further studied the differences in Livin isoforms, Livin-and Livin-, in Hela cells and demonstrated that they strongly differ in functional significance for the antiapoptotic resistance of tumor cells. The Livin-but not the Livin-isoform plays a key role in the antiapoptotic protection of HeLa cells. 26) Dina Ben Yehuda demonstrated that both Livin isoforms have significant antiapoptotic activity in Jurkat T cells after triggering apoptosis via TNF-alpha and CD95 receptors. Livin-, but not Livin-, protects cells from apoptosis induced by staurosporine. However, apoptosis initiated by etoposide was blocked only by Livin-. 27) In this study, we found that only Livin-, not Livin-, was expressed in bladder cancer cells both at the mRNA and the protein level. Suppress Livinpotently inhibits bladder cancer cell growth and increases cell apoptotic sensitivity to TNF-alpha and mitomycin. These functional and the tissue distribution differences in Livin-and Livin-suggest that Livin plays a complex role in the regulation of apoptosis.
Besides Livin, other IAPs, such as Suvivin and XIAP, were also reported to be overexpressed in bladder cancer. Hou reported that knockdown Survivin expression in bladder cancer T24 cells markedly induced apoptosis and inhibited cell growth in vitro and in vivo.
28) Vladimir Bilim reported that XIAP was overexpressed in bladder cancer tissues and was correlated with resistance to chemotherapy. Overexpression of XIAP in T24 cells resulted in a significant survival advantage as compared to parental cells. 29) In this study, we found that Livin, like Survivin and XIAP, also correlated with T24 cell survival ability and resistance to apoptosis. Fig. 5 . siRNA-Livin Promoted T24 Cell Apoptosis by Increasing Caspase-3 and Caspase-9, but not Caspase-7, Activation.
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The siRNAs inhibiting Livin expression increased active caspase-3 and active caspase-9 especially in the presence of apoptotic stimulus, while there was no significant difference of active caspase-7 expression between the siRNA-NC and the siRNA-Livin group in the absence and the presence of an apoptotic stimulus in T24 cells. Data were obtained from three independent experiments. The relative signal intensities of the active caspase-3, active caspase-7, and active caspase-9 protein levels as compared with GAPDH were analyzed by LabWorks (TM ver4.6, UVP, BioImaging Systems, Upland, CA) ( Ã p < 0:05).
These results suggest that apoptosis in bladder cancer is regulated by multiple IAPs members including Livin, Survivin, and XIAP. These structurally similar and functionally overlapping IAPs might regulate each other and themselves by the ubiquitin-proteasome pathway, and might have a synergistic effect in inhibiting cell apoptosis. However, the exact mechanisms remain unknown and require further study. Above all, our present in vitro study indicates that siRNA-mediated Livin suppression effectively inhibited proliferation and promoted apoptotic sensitivity in bladder cancer cells. Thus, it might be a promising approach to treat bladder cancer in the clinic. However, much work remains to be conducted on this therapeutic strategy: (i) The relationship between Livin and other molecules, such as other IAP members, the BCL-2 family, the caspase family, and cytochrome c, involved in the apoptosis pathway, requires further study. (ii) In vivo study should be conducted to evaluate further the therapeutic effects of Livin siRNAs in bladder cancer. (iii) In order to apply siRNAs as drugs, the technical hurdle of efficiently delivering them into the target cells still has to be overcome. Ultrasound mediated siRNA transfection was reported to promote transfection specificity and efficiency greatly. 30, 31) However, it requires further in vivo study to determine whether this technique can provide a new route for siRNA mediated gene therapy.
